RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-0.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.76B
AUM Growth
+$4.76B
(-5.8%)
Cap. Flow
+$78.2M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
26.26%
Holding
166
New
11
Increased
69
Reduced
16
Closed
13
Top Buys
| 1 |
Baxter International
BAX
|
$36.2M |
| 2 |
Warby Parker
WRBY
|
$34.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$30.3M |
| 4 |
Immuneering
IMRX
|
$28.9M |
| 5 |
Ascendis Pharma
ASND
|
$26.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$68.6M |
| 2 |
Ardelyx
ARDX
|
$39.8M |
| 3 |
Biogen
BIIB
|
$39.3M |
| 4 |
Boston Scientific
BSX
|
$34.2M |
| 5 |
PPD
PPD, Inc. Common Stock
PPD
|
$31.1M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Consumer Staples | 1.58% |
| 3 | Industrials | 0.82% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Agilon Health
AGL
$530M
| $185M | 3.9% | 7,075,000 +75,977 | +1% | +$1.99M |
|
2
Humana
HUM
$36.5B
| $133M | 2.8% | 342,000 +39,500 | +13% | +$15.4M |
|
3
Align Technology
ALGN
$10.3B
| $133M | 2.8% | 200,000 +12,250 | +7% | +$8.15M |
|
4
Insulet
PODD
$23.9B
| $124M | 2.62% | 437,566 +28,816 | +7% | +$8.19M |
|
5
Intuitive Surgical
ISRG
$170B
| $119M | 2.51% | 120,000 | – | – |
|
6
Agios Pharmaceuticals
AGIO
$2.19B
| $118M | 2.48% | 2,556,179 -18,129 | -0.7% | -$837K |
|
7
Zai Lab
ZLAB
$3.68B
| $114M | 2.39% | 1,077,750 +63,750 | +6% | +$6.72M |
|
8
Idexx Laboratories
IDXX
$51.8B
| $112M | 2.35% | 180,000 | – | – |
|
9
HCA Healthcare
HCA
$94.5B
| $109M | 2.3% | 450,000 | – | – |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $101M | 2.12% | 1,051,500 +36,500 | +4% | +$3.5M |
|
11
argenx
ARGX
$43.6B
| $95.1M | 2% | 315,000 | – | – |
|
12
Novavax
NVAX
$1.21B
| $94.3M | 1.98% | 455,000 | – | – |
|
13
UnitedHealth
UNH
$281B
| $93.8M | 1.97% | 240,000 | – | – |
|
14
Immunocore
IMCR
$1.62B
| $90.6M | 1.91% | 2,445,155 +50,370 | +2% | +$1.87M |
|
|
BPMC
15
DELISTED
Blueprint Medicines
BPMC
| $87.4M | 1.84% | 849,659 +40,799 | +5% | +$4.19M |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $76.9M | 1.62% | 702,000 +77,000 | +12% | +$8.43M |
|
17
Freshpet
FRPT
$2.72B
| $75.2M | 1.58% | 527,000 +20,500 | +4% | +$2.93M |
|
|
NVTA
18
DELISTED
Invitae Corporation
NVTA
| $74.1M | 1.56% | 2,605,829 +303,797 | +13% | +$8.64M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $74M | 1.56% | 635,700 +104,700 | +20% | +$12.2M |
|
|
20
Ultragenyx Pharmaceutical
RARE
$2.89B
| $72.3M | 1.52% | 801,109 +336,109 | +72% | +$30.3M |
|
21
Aclaris Therapeutics
ACRS
$209M
| $68.5M | 1.44% | 3,803,232 +40,920 | +1% | +$737K |
|
22
Edwards Lifesciences
EW
$47.8B
| $65.9M | 1.39% | 582,000 | – | – |
|
|
23
Ascendis Pharma
ASND
$11.8B
| $63.8M | 1.34% | 400,000 +166,500 | +71% | +$26.5M |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $62.5M | 1.32% | 353,514 +34,429 | +11% | +$6.09M |
|
25
Phreesia
PHR
$1.88B
| $59.8M | 1.26% | 970,000 +10,000 | +1% | +$617K |
|